235 related articles for article (PubMed ID: 33946414)
1. Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes.
Parvathaneni V; Elbatanony RS; Goyal M; Chavan T; Vega N; Kolluru S; Muth A; Gupta V; Kunda NK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946414
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin Complexation for Enhanced Stability and Non-invasive Pulmonary Delivery of Resveratrol-Applications in Non-small Cell Lung Cancer Treatment.
Wang X; Parvathaneni V; Shukla SK; Kanabar DD; Muth A; Gupta V
AAPS PharmSciTech; 2020 Jul; 21(5):183. PubMed ID: 32632576
[TBL] [Abstract][Full Text] [Related]
3. Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer.
Wang X; Parvathaneni V; Shukla SK; Kulkarni NS; Muth A; Kunda NK; Gupta V
Int J Biol Macromol; 2020 Dec; 164():638-650. PubMed ID: 32693132
[TBL] [Abstract][Full Text] [Related]
4. Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC).
Patil SM; Sawant SS; Kunda NK
Int J Pharm; 2021 Sep; 607():121046. PubMed ID: 34450225
[TBL] [Abstract][Full Text] [Related]
5. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
Parvathaneni V; Kulkarni NS; Chauhan G; Shukla SK; Elbatanony R; Patel B; Kunda NK; Muth A; Gupta V
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111139. PubMed ID: 32600728
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine anticancer activity enhancement by water soluble celecoxib/sulfobutyl ether-β-cyclodextrin inclusion complex.
Rescifina A; Surdo E; Cardile V; Avola R; Eleonora Graziano AC; Stancanelli R; Tommasini S; Pistarà V; Ventura CA
Carbohydr Polym; 2019 Feb; 206():792-800. PubMed ID: 30553385
[TBL] [Abstract][Full Text] [Related]
8. Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study.
Ren L; Wang J; Chen G
Drug Deliv; 2019 Dec; 26(1):309-317. PubMed ID: 30896265
[TBL] [Abstract][Full Text] [Related]
9. Erlotinib complexation with randomly methylated
Erdoğar N; Akkın S; Varan G; Bilensoy E
Pharm Dev Technol; 2021 Sep; 26(7):797-806. PubMed ID: 34219578
[TBL] [Abstract][Full Text] [Related]
10. Design and development of dry powder sulfobutylether-β-cyclodextrin complex for pulmonary delivery of fisetin.
Mohtar N; Taylor KM; Sheikh K; Somavarapu S
Eur J Pharm Biopharm; 2017 Apr; 113():1-10. PubMed ID: 27916704
[TBL] [Abstract][Full Text] [Related]
11. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
Jain AS; Date AA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS
AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
[TBL] [Abstract][Full Text] [Related]
13. Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline.
Rawal T; Patel S; Butani S
Eur J Pharm Sci; 2018 Nov; 124():273-287. PubMed ID: 30176365
[TBL] [Abstract][Full Text] [Related]
14. Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment.
Patil SM; Barji DS; Chavan T; Patel K; Collazo AJ; Prithipaul V; Muth A; Kunda NK
AAPS PharmSciTech; 2023 Jan; 24(1):49. PubMed ID: 36702977
[TBL] [Abstract][Full Text] [Related]
15. Preparation and
Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A.
Ren L; Jing J; Chen G; Miao Y; Wei P
J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809
[TBL] [Abstract][Full Text] [Related]
17. Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy.
Elbatanony RS; Parvathaneni V; Kulkarni NS; Shukla SK; Chauhan G; Kunda NK; Gupta V
Drug Deliv Transl Res; 2021 Jun; 11(3):927-943. PubMed ID: 32557351
[TBL] [Abstract][Full Text] [Related]
18. Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
Rangnekar B; Momin MAM; Eedara BB; Sinha S; Das SC
Int J Pharm; 2019 Oct; 570():118689. PubMed ID: 31513868
[TBL] [Abstract][Full Text] [Related]
19. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.
Jyoti K; Pandey RS; Kush P; Kaushik D; Jain UK; Madan J
Int J Biol Macromol; 2017 May; 98():50-58. PubMed ID: 28130133
[TBL] [Abstract][Full Text] [Related]
20. Molecular recognition and enhancement of aqueous solubility and bioactivity of CD437 by β-cyclodextrin.
Mishur RJ; Griffin ME; Battle CH; Shan B; Jayawickramarajah J
Bioorg Med Chem Lett; 2011 Jan; 21(2):857-60. PubMed ID: 21185186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
